JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Single-stage laryngotracheoplasty in children.

Auris, Nasus, Larynx 2011 December
OBJECTIVE: To review the outcomes of pediatric patients with laryngotracheal stenosis treated by single-stage laryngotracheoplasty.

METHODS: A single surgeon personal series retrospective review of 15 children undergoing single-stage laryngotracheoplasty for laryngeal stenosis over 4-year period (2004-2008).

RESULTS: 15 patients (9 boys and 6 girls), with ages ranging from 1 month to 18 years, were operated. Using the Myer-Cotton grading system, 2 patients were diagnosed with grade 4 stenosis, 6 patients with grade 3 and 7 patients with grade 2. In10 cases, an LTP with anterior costal cartilage graft was performed; in one case an anterior and posterior LTP; in one case a partial cricotracheal resection and in 3 cases an anterior cricoids split. The overall success rate was 94%.

CONCLUSION: Single stage laryngotracheoplasty is a safe and effective method for laryngotracheal stenosis in children.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app